Furthermore, for the first time we revealed positive association between PD-L1+myeloid cells and sPD-L1 in the blood, indicate that sPD-L1 may be a noninvasive surrogate marker for surface expression of PD-L1 on myeloid cells in immunomonitoring of ovarian cancer patients. The gene discussed is CD274; the disease is ovarian carcinoma.